APO Research

APO RESEARCH · REPORT

Plant-based Cannabidiol (CBD) Nutraceuticals

Selected research

Industry Research

Plant-based Cannabidiol (CBD) Nutraceuticals Industry Research Report 2026

Market perspective

The global Plant-based Cannabidiol (CBD) Nutraceuticals market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Plant-based Cannabidiol (CBD) Nutraceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Plant-based Cannabidiol (CBD) Nutraceuticals is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Plant-based Cannabidiol (CBD) Nutraceuticals is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Plant-based Cannabidiol (CBD) Nutraceuticals include Medical Marijuana, Inc, Isodiol, Irwin Naturals, Green Roads, Garden of Life, Foria Wellness, Diamond CBD and CV Sciences, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Plant-based Cannabidiol (CBD) Nutraceuticals market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Plant-based Cannabidiol (CBD) Nutraceuticals Market by Company

Medical Marijuana, Inc

Isodiol

Irwin Naturals

Green Roads

Garden of Life

Foria Wellness

Diamond CBD

CV Sciences, Inc.

Plant-based Cannabidiol (CBD) Nutraceuticals Segment by Type

Capsules & Softgels

CBD Gummies

CBD Tinctures

Others

Plant-based Cannabidiol (CBD) Nutraceuticals Segment by Application

Retail Stores

Online Sales

Pharmacies

Plant-based Cannabidiol (CBD) Nutraceuticals Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plant-based Cannabidiol (CBD) Nutraceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plant-based Cannabidiol (CBD) Nutraceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plant-based Cannabidiol (CBD) Nutraceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Plant-based Cannabidiol (CBD) Nutraceuticals manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Plant-based Cannabidiol (CBD) Nutraceuticals by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Plant-based Cannabidiol (CBD) Nutraceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Plant-based Cannabidiol (CBD) Nutraceuticals Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Market Share by Manufacturers (2021-2026) Table 8. Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue of Manufacturers (2021-2026) Table 9. Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Plant-based Cannabidiol (CBD) Nutraceuticals Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Plant-based Cannabidiol (CBD) Nutraceuticals Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Plant-based Cannabidiol (CBD) Nutraceuticals, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Plant-based Cannabidiol (CBD) Nutraceuticals, Product Type & Application Table 14. Global Plant-based Cannabidiol (CBD) Nutraceuticals Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Plant-based Cannabidiol (CBD) Nutraceuticals by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Medical Marijuana, Inc Company Information Table 19. Medical Marijuana, Inc Business Overview Table 20. Medical Marijuana, Inc Plant-based Cannabidiol (CBD) Nutraceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Medical Marijuana, Inc Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio Table 22. Medical Marijuana, Inc Recent Developments Table 23. Isodiol Company Information Table 24. Isodiol Business Overview Table 25. Isodiol Plant-based Cannabidiol (CBD) Nutraceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Isodiol Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio Table 27. Isodiol Recent Developments Table 28. Irwin Naturals Company Information Table 29. Irwin Naturals Business Overview Table 30. Irwin Naturals Plant-based Cannabidiol (CBD) Nutraceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Irwin Naturals Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio Table 32. Irwin Naturals Recent Developments Table 33. Green Roads Company Information Table 34. Green Roads Business Overview Table 35. Green Roads Plant-based Cannabidiol (CBD) Nutraceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Green Roads Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio Table 37. Green Roads Recent Developments Table 38. Garden of Life Company Information Table 39. Garden of Life Business Overview Table 40. Garden of Life Plant-based Cannabidiol (CBD) Nutraceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Garden of Life Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio Table 42. Garden of Life Recent Developments Table 43. Foria Wellness Company Information Table 44. Foria Wellness Business Overview Table 45. Foria Wellness Plant-based Cannabidiol (CBD) Nutraceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Foria Wellness Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio Table 47. Foria Wellness Recent Developments Table 48. Diamond CBD Company Information Table 49. Diamond CBD Business Overview Table 50. Diamond CBD Plant-based Cannabidiol (CBD) Nutraceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Diamond CBD Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio Table 52. Diamond CBD Recent Developments Table 53. CV Sciences, Inc. Company Information Table 54. CV Sciences, Inc. Business Overview Table 55. CV Sciences, Inc. Plant-based Cannabidiol (CBD) Nutraceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. CV Sciences, Inc. Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio Table 57. CV Sciences, Inc. Recent Developments Table 58. Global Plant-based Cannabidiol (CBD) Nutraceuticals Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 59. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Region (2021-2026) & (K Units) Table 60. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Market Share by Region (2021-2026) Table 61. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Region (2027-2032) & (K Units) Table 62. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Market Share by Region (2027-2032) Table 63. Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Market Share by Region (2021-2026) Table 65. Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Market Share by Region (2027-2032) Table 67. North America Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 68. North America Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Country (2021-2026) & (K Units) Table 69. North America Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Country (2027-2032) & (K Units) Table 70. North America Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Country (2021-2026) & (US$ Million) Table 71. North America Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Country (2027-2032) & (US$ Million) Table 72. Europe Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. Europe Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Country (2021-2026) & (K Units) Table 74. Europe Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Country (2027-2032) & (K Units) Table 75. Europe Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Country (2021-2026) & (US$ Million) Table 76. Europe Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Country (2027-2032) & (US$ Million) Table 77. Asia Pacific Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. Asia Pacific Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Country (2021-2026) & (K Units) Table 79. Asia Pacific Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Country (2027-2032) & (K Units) Table 80. Asia Pacific Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Country (2021-2026) & (US$ Million) Table 81. Asia Pacific Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Country (2027-2032) & (US$ Million) Table 82. South America Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. South America Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Country (2021-2026) & (K Units) Table 84. South America Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Country (2027-2032) & (K Units) Table 85. South America Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Country (2021-2026) & (US$ Million) Table 86. South America Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Country (2027-2032) & (US$ Million) Table 87. Middle East and Africa Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Middle East and Africa Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Country (2021-2026) & (K Units) Table 89. Middle East and Africa Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Country (2027-2032) & (K Units) Table 90. Middle East and Africa Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Country (2021-2026) & (US$ Million) Table 91. Middle East and Africa Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Country (2027-2032) & (US$ Million) Table 92. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Type (2021-2026) & (K Units) Table 93. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Type (2027-2032) & (K Units) Table 94. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Market Share by Type (2021-2026) Table 95. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Market Share by Type (2027-2032) Table 96. Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Type (2021-2026) & (US$ Million) Table 97. Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Type (2027-2032) & (US$ Million) Table 98. Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Market Share by Type (2021-2026) Table 99. Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Market Share by Type (2027-2032) Table 100. Global Plant-based Cannabidiol (CBD) Nutraceuticals Price by Type (2021-2026) & (US$/Unit) Table 101. Global Plant-based Cannabidiol (CBD) Nutraceuticals Price by Type (2027-2032) & (US$/Unit) Table 102. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Application (2021-2026) & (K Units) Table 103. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Application (2027-2032) & (K Units) Table 104. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Market Share by Application (2021-2026) Table 105. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Market Share by Application (2027-2032) Table 106. Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Application (2021-2026) & (US$ Million) Table 107. Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Application (2027-2032) & (US$ Million) Table 108. Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Market Share by Application (2021-2026) Table 109. Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Market Share by Application (2027-2032) Table 110. Global Plant-based Cannabidiol (CBD) Nutraceuticals Price by Application (2021-2026) & (US$/Unit) Table 111. Global Plant-based Cannabidiol (CBD) Nutraceuticals Price by Application (2027-2032) & (US$/Unit) Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Plant-based Cannabidiol (CBD) Nutraceuticals Distributors List Table 115. Plant-based Cannabidiol (CBD) Nutraceuticals Customers List Table 116. Plant-based Cannabidiol (CBD) Nutraceuticals Industry Trends Table 117. Plant-based Cannabidiol (CBD) Nutraceuticals Industry Drivers Table 118. Plant-based Cannabidiol (CBD) Nutraceuticals Industry Restraints Table 119. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Plant-based Cannabidiol (CBD) Nutraceuticals Product Image Figure 5. Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Plant-based Cannabidiol (CBD) Nutraceuticals Market Size (2021-2032) & (US$ Million) Figure 7. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales (2021-2032) & (K Units) Figure 8. Global Plant-based Cannabidiol (CBD) Nutraceuticals Average Price (US$/Unit) & (2021-2032) Figure 9. Capsules & Softgels Product Image Figure 10. CBD Gummies Product Image Figure 11. CBD Tinctures Product Image Figure 12. Others Product Image Figure 13. Retail Stores Product Image Figure 14. Online Sales Product Image Figure 15. Pharmacies Product Image Figure 16. Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Plant-based Cannabidiol (CBD) Nutraceuticals, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Plant-based Cannabidiol (CBD) Nutraceuticals Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Plant-based Cannabidiol (CBD) Nutraceuticals Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Region in 2025 Figure 22. Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Region in 2025 Figure 23. North America Plant-based Cannabidiol (CBD) Nutraceuticals Market Size by Country in 2025 Figure 24. North America Plant-based Cannabidiol (CBD) Nutraceuticals Sales Market Share by Country (2021-2032) Figure 25. North America Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Market Share by Country (2021-2032) Figure 26. United States Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Plant-based Cannabidiol (CBD) Nutraceuticals Market Size by Country in 2025 Figure 29. Europe Plant-based Cannabidiol (CBD) Nutraceuticals Sales Market Share by Country (2021-2032) Figure 30. Europe Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Market Share by Country (2021-2032) Figure 31. Germany Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Asia Pacific Plant-based Cannabidiol (CBD) Nutraceuticals Market Size by Country in 2025 Figure 37. Asia Pacific Plant-based Cannabidiol (CBD) Nutraceuticals Sales Market Share by Country (2021-2032) Figure 38. Asia Pacific Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Market Share by Country (2021-2032) Figure 39. China Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Japan Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. South Korea Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. India Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Australia Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. China Taiwan Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Southeast Asia Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South America Plant-based Cannabidiol (CBD) Nutraceuticals Market Size by Country in 2025 Figure 48. South America Plant-based Cannabidiol (CBD) Nutraceuticals Sales Market Share by Country (2021-2032) Figure 49. South America Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Market Share by Country (2021-2032) Figure 50. Mexico Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Brazil Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Argentina Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Middle East and Africa Plant-based Cannabidiol (CBD) Nutraceuticals Market Size by Country in 2025 Figure 54. Middle East and Africa Plant-based Cannabidiol (CBD) Nutraceuticals Sales Market Share by Country (2021-2032) Figure 55. Middle East and Africa Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Market Share by Country (2021-2032) Figure 56. Turkey Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Saudi Arabia Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. UAE Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Market Share by Type (2021-2032) Figure 60. Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Market Share by Type (2021-2032) Figure 61. Global Plant-based Cannabidiol (CBD) Nutraceuticals Price (US$/Unit) by Type (2021-2032) Figure 62. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Market Share by Application (2021-2032) Figure 63. Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Market Share by Application (2021-2032) Figure 64. Global Plant-based Cannabidiol (CBD) Nutraceuticals Price (US$/Unit) by Application (2021-2032) Figure 65. Plant-based Cannabidiol (CBD) Nutraceuticals Value Chain Figure 66. Plant-based Cannabidiol (CBD) Nutraceuticals Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Plant-based Cannabidiol (CBD) Nutraceuticals Industry Opportunities and Challenges

Scope & coverage.

Types
  • Capsules & Softgels
  • CBD Gummies
  • CBD Tinctures
  • Others
Applications
  • Retail Stores
  • Online Sales
  • Pharmacies
Companies covered
  • Medical Marijuana, Inc
  • Isodiol
  • Irwin Naturals
  • Green Roads
  • Garden of Life
  • Foria Wellness
  • Diamond CBD
  • CV Sciences, Inc.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Plant-based Cannabidiol (CBD) Nutraceuticals Market Size (2021-2032)
  4. 2.2.2 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales (2021-2032)
  5. 2.2.3 Global Plant-based Cannabidiol (CBD) Nutraceuticals Market Average Price (2021-2032)
  6. 2.3 Plant-based Cannabidiol (CBD) Nutraceuticals by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Capsules & Softgels
  9. 2.3.3 CBD Gummies
  10. 2.3.4 CBD Tinctures
  11. 2.3.5 Others
  12. 2.4 Plant-based Cannabidiol (CBD) Nutraceuticals by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Retail Stores
  15. 2.4.3 Online Sales
  16. 2.4.4 Pharmacies
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Plant-based Cannabidiol (CBD) Nutraceuticals Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Plant-based Cannabidiol (CBD) Nutraceuticals Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Plant-based Cannabidiol (CBD) Nutraceuticals Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Plant-based Cannabidiol (CBD) Nutraceuticals, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Plant-based Cannabidiol (CBD) Nutraceuticals, Product Type & Application
  8. 3.8 Global Manufacturers of Plant-based Cannabidiol (CBD) Nutraceuticals, Established Date
  9. 3.9 Global Plant-based Cannabidiol (CBD) Nutraceuticals Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Medical Marijuana, Inc
  2. 4.1.1 Medical Marijuana, Inc Company Information
  3. 4.1.2 Medical Marijuana, Inc Business Overview
  4. 4.1.3 Medical Marijuana, Inc Plant-based Cannabidiol (CBD) Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Medical Marijuana, Inc Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio
  6. 4.1.5 Medical Marijuana, Inc Recent Developments
  7. 4.2 Isodiol
  8. 4.2.1 Isodiol Company Information
  9. 4.2.2 Isodiol Business Overview
  10. 4.2.3 Isodiol Plant-based Cannabidiol (CBD) Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Isodiol Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio
  12. 4.2.5 Isodiol Recent Developments
  13. 4.3 Irwin Naturals
  14. 4.3.1 Irwin Naturals Company Information
  15. 4.3.2 Irwin Naturals Business Overview
  16. 4.3.3 Irwin Naturals Plant-based Cannabidiol (CBD) Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Irwin Naturals Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio
  18. 4.3.5 Irwin Naturals Recent Developments
  19. 4.4 Green Roads
  20. 4.4.1 Green Roads Company Information
  21. 4.4.2 Green Roads Business Overview
  22. 4.4.3 Green Roads Plant-based Cannabidiol (CBD) Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Green Roads Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio
  24. 4.4.5 Green Roads Recent Developments
  25. 4.5 Garden of Life
  26. 4.5.1 Garden of Life Company Information
  27. 4.5.2 Garden of Life Business Overview
  28. 4.5.3 Garden of Life Plant-based Cannabidiol (CBD) Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Garden of Life Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio
  30. 4.5.5 Garden of Life Recent Developments
  31. 4.6 Foria Wellness
  32. 4.6.1 Foria Wellness Company Information
  33. 4.6.2 Foria Wellness Business Overview
  34. 4.6.3 Foria Wellness Plant-based Cannabidiol (CBD) Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Foria Wellness Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio
  36. 4.6.5 Foria Wellness Recent Developments
  37. 4.7 Diamond CBD
  38. 4.7.1 Diamond CBD Company Information
  39. 4.7.2 Diamond CBD Business Overview
  40. 4.7.3 Diamond CBD Plant-based Cannabidiol (CBD) Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Diamond CBD Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio
  42. 4.7.5 Diamond CBD Recent Developments
  43. 4.8 CV Sciences, Inc.
  44. 4.8.1 CV Sciences, Inc. Company Information
  45. 4.8.2 CV Sciences, Inc. Business Overview
  46. 4.8.3 CV Sciences, Inc. Plant-based Cannabidiol (CBD) Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 CV Sciences, Inc. Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio
  48. 4.8.5 CV Sciences, Inc. Recent Developments
5 Global Plant-based Cannabidiol (CBD) Nutraceuticals Market Scenario by Region
  1. 5.1 Global Plant-based Cannabidiol (CBD) Nutraceuticals Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Region: 2021-2032
  3. 5.2.1 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Region: 2021-2026
  4. 5.2.2 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Region: 2027-2032
  5. 5.3 Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Region: 2021-2032
  6. 5.3.1 Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Region: 2021-2026
  7. 5.3.2 Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Region: 2027-2032
  8. 5.4 North America Plant-based Cannabidiol (CBD) Nutraceuticals Market Facts & Figures by Country
  9. 5.4.1 North America Plant-based Cannabidiol (CBD) Nutraceuticals Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Country (2021-2032)
  11. 5.4.3 North America Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Plant-based Cannabidiol (CBD) Nutraceuticals Market Facts & Figures by Country
  15. 5.5.1 Europe Plant-based Cannabidiol (CBD) Nutraceuticals Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Country (2021-2032)
  17. 5.5.3 Europe Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Plant-based Cannabidiol (CBD) Nutraceuticals Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Plant-based Cannabidiol (CBD) Nutraceuticals Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Plant-based Cannabidiol (CBD) Nutraceuticals Market Facts & Figures by Country
  35. 5.7.1 South America Plant-based Cannabidiol (CBD) Nutraceuticals Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Country (2021-2032)
  37. 5.7.3 South America Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Plant-based Cannabidiol (CBD) Nutraceuticals Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Plant-based Cannabidiol (CBD) Nutraceuticals Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Type (2021-2032)
  2. 6.1.1 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Market Share by Type (2021-2032)
  4. 6.2 Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Type (2021-2032)
  5. 6.2.1 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Plant-based Cannabidiol (CBD) Nutraceuticals Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Application (2021-2032)
  2. 7.1.1 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Market Share by Application (2021-2032)
  4. 7.2 Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Application (2021-2032)
  5. 7.2.1 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Plant-based Cannabidiol (CBD) Nutraceuticals Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Plant-based Cannabidiol (CBD) Nutraceuticals Value Chain Analysis
  2. 8.1.1 Plant-based Cannabidiol (CBD) Nutraceuticals Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Plant-based Cannabidiol (CBD) Nutraceuticals Production Mode & Process
  5. 8.2 Plant-based Cannabidiol (CBD) Nutraceuticals Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Plant-based Cannabidiol (CBD) Nutraceuticals Distributors
  8. 8.2.3 Plant-based Cannabidiol (CBD) Nutraceuticals Customers
9 Global Plant-based Cannabidiol (CBD) Nutraceuticals Analyzing Market Dynamics
  1. 9.1 Plant-based Cannabidiol (CBD) Nutraceuticals Industry Trends
  2. 9.2 Plant-based Cannabidiol (CBD) Nutraceuticals Industry Drivers
  3. 9.3 Plant-based Cannabidiol (CBD) Nutraceuticals Industry Opportunities and Challenges
  4. 9.4 Plant-based Cannabidiol (CBD) Nutraceuticals Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research